The treatment of retroperitoneal fibromatosis with medroxyprogesterone acetate.
Wide excision is the recommended primary therapy for retroperitoneal fibromatosis. Radiation therapy and a variety of medications have been used to treat patients with recurrent tumors, but the response to these agents has not been uniform. The patient presented was successfully treated with medroxyprogesterone acetate for recurrent retroperitoneal fibromatosis that was refractory to multiple operative resections and radiation therapy.
D000328:Adult; D005260:Female; D006801:Humans; D008525:Medroxyprogesterone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017258:Medroxyprogesterone Acetate; D011247:Pregnancy; D011248:Pregnancy Complications / Q000601:surgery; D011644:Puerperal Disorders / Q000532:radiotherapy / Q000601:surgery; D012008:Recurrence; D012185:Retroperitoneal Fibrosis / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery
D017258:Medroxyprogesterone Acetate; D008525:Medroxyprogesterone